FIELD: medicine.
SUBSTANCE: invention can be applicable for treating patients suffering haemorrhagic shock. Namely, the invention refers to a hyperoxygenated agent for venous oxygen saturation, which represents an aqueous solution containing sodium chloride 0.85%, sodium hydroxycarbonate 0.10% and hydrogen peroxide 0.05-0.29%.
EFFECT: higher safety and effectiveness by blood oxygen saturation, stable osmotic activity, higher alkalinity and buffer capacity.
| Title | Year | Author | Number |
|---|---|---|---|
| LYMPHO-SUBSITUTE FOR LOCAL MAINTAINING VIABILITY OF ORGANS AND TISSUES IN HYPOXIA AND ISCHEMIA | 2015 |
|
RU2586292C1 |
| DECOLORANT OF BLOOD | 2016 |
|
RU2647371C1 |
| BLEACHING AGENT | 2014 |
|
RU2589682C1 |
| AGENT FOR INCREASING RESISTANCE TO HYPOXIA | 2015 |
|
RU2604129C2 |
| BRUISE BLEACHER | 2014 |
|
RU2539380C1 |
| AGENT FOR INTRADERMAL BRUISE WHITENING | 2015 |
|
RU2573382C1 |
| MEANS FOR PHYSICAL ENDURANCE INCREASE | 2016 |
|
RU2634271C1 |
| ENERGY DRINK | 2016 |
|
RU2639493C1 |
| BLEACHING OPENER OF DRIED BLOOD FOR WRAPPING BANDAGES ADHERED TO A WOUND | 2016 |
|
RU2653465C1 |
| OXYGENATED WARM ALKALINE HYDROGEN PEROXIDE SOLUTION FOR INTRAPULMONARY INJECTION | 2023 |
|
RU2831821C1 |
Authors
Dates
2015-01-10—Published
2013-10-17—Filed